Literature DB >> 19864230

Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.

Gabriela Gualco1, Lucimara Chioato, Lawrence M Weiss, William J Harrington, Carlos E Bacchi.   

Abstract

Anaplastic large cell lymphoma (ALCL) is recognized as 2 distinct diseases: anaplastic lymphoma kinase (ALK)+ ALCL and ALK- ALCL. ALK+ ALCL occurs in younger patients and has a better prognosis. Human T-cell lymphotropic virus (HTLV-1) is linked to the development of adult T-cell leukemia/lymphoma (ATLL), which frequently expresses CD25. CD25 is significantly expressed in childhood ALCL. In Brazil, HTLV-1 infection is endemic, and vertical transmission is responsible for spread to children. Of HTLV-1 carriers, 90% or more remain asymptomatic. Some cases of adult HTLV-1-related lymphomas have characteristics of ALCL but are considered CD30+ ATLL subtypes. No similar cases have been described in children. We analyzed 33 cases of pediatric ALCL, CD25+ and CD25-, for proviral HTLV-1 DNA. All cases corresponded to the common histologic ALCL type and were CD30+ in virtually all neoplastic cells. ALK expression was observed in 31 (94%) of 33 cases; CD25 was positive in 27 (82%), including 1 ALK- ALCL case. There was a strong positive correlation between ALK and CD25 expression. None of the cases showed proviral HTLV-1 DNA. ALCL in children has no relationship with HTLV-1; the frequent CD25 expression must be explained by a mechanism different from that in ATLL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864230      PMCID: PMC2771325          DOI: 10.1309/AJCP6Q7QMUVGMVMF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  32 in total

1.  Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy.

Authors:  Dan Jones; Sherif Ibrahim; Kaushali Patel; Rajyalakshmi Luthra; Madeleine Duvic; L Jeffrey Medeiros
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

2.  Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus.

Authors:  M M Bacchi; C E Bacchi; M Alvarenga; R Miranda; Y Y Chen; L M Weiss
Journal:  Mod Pathol       Date:  1996-01       Impact factor: 7.842

3.  DNA extraction from paraffin-embedded tissues using a salting-out procedure: a reliable method for PCR amplification of archival material.

Authors:  J R Howe; D S Klimstra; C Cordon-Cardo
Journal:  Histol Histopathol       Date:  1997-07       Impact factor: 2.303

4.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

5.  Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma.

Authors:  M Setoyama; F A Kerdel; G Elgart; T Kanzaki; J J Byrnes
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 6.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

7.  A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children.

Authors:  Elizabeth M Maloney; Stefan Z Wiktor; Paulette Palmer; Beverley Cranston; Ernest J Pate; Sylvia Cohn; Norma Kim; Wendell Miley; Terry L Thomas; William A Blattner; Barrie Hanchard
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

8.  A patient with anaplastic large cell lymphoma (Ki-1 lymphoma) showing clonal integration of HTLV-1 proviral DNA.

Authors:  Y Takimoto; H Tanaka; O Tanabe; A Kuramoto; N Sasaki; K Nanba
Journal:  Leukemia       Date:  1994-03       Impact factor: 11.528

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

10.  CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area.

Authors:  M Takeshita; K Ohshima; M Akamatsu; A Ohgami; M Kikuchi; J Suzumiya; N Uike; T Okamura; J Nakayama
Journal:  Hum Pathol       Date:  1995-06       Impact factor: 3.466

View more
  5 in total

1.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

2.  On the general theory of the origins of retroviruses.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2010-02-16       Impact factor: 2.432

3.  Pediatric lymphomas in Brazil.

Authors:  Gabriela Gualco; Claudete E Klumb; Glen N Barber; Lawrence M Weiss; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations.

Authors:  N Shahriari; K Ferenczi; P W Heald
Journal:  Int J Womens Dermatol       Date:  2017-07-11

Review 5.  Novel targeted therapies of T cell lymphomas.

Authors:  Katarzyna Iżykowska; Karolina Rassek; Dorota Korsak; Grzegorz K Przybylski
Journal:  J Hematol Oncol       Date:  2020-12-31       Impact factor: 17.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.